CENTAURUS FINANCIAL, INC. - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 63 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
CENTAURUS FINANCIAL, INC. ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$23
-99.9%
20,7320.0%0.00%
-33.3%
Q3 2022$34,000
+25.9%
20,732
-1.0%
0.00%0.0%
Q2 2022$27,000
-20.6%
20,947
-0.8%
0.00%0.0%
Q1 2022$34,000
-61.4%
21,114
-6.6%
0.00%
-57.1%
Q3 2021$88,000
+76.0%
22,614
+44.8%
0.01%
+75.0%
Q2 2021$50,000
+47.1%
15,6140.0%0.00%
+33.3%
Q1 2021$34,000
-2.9%
15,6140.0%0.00%
-25.0%
Q4 2020$35,000
-16.7%
15,6140.0%0.00%
-33.3%
Q3 2020$42,000
-12.5%
15,6140.0%0.01%
-14.3%
Q2 2020$48,000
+60.0%
15,614
+2.7%
0.01%
+16.7%
Q1 2020$30,000
-31.8%
15,201
-0.4%
0.01%0.0%
Q4 2019$44,000
-21.4%
15,2630.0%0.01%
-33.3%
Q3 2019$56,000
-18.8%
15,263
-7.8%
0.01%
-18.2%
Q2 2019$69,000
-99.6%
16,563
+20098.8%
0.01%
-88.4%
Q1 2019$16,129,000
+26781.7%
82
+720.0%
0.10%
+763.6%
Q3 2018$60,000
-43.4%
10
-99.9%
0.01%
-26.7%
Q2 2018$106,000
+125.5%
16,712
+67.1%
0.02%
+36.4%
Q1 2018$47,000
+42.4%
10,0000.0%0.01%
+22.2%
Q4 2017$33,00010,0000.01%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$248,6170.07%
Geneos Wealth Management Inc. 417,350$801,3120.04%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$23,0400.02%
RETIREMENT GUYS FORMULA LLC 11,500$22,0800.02%
Vivaldi Capital Management LP 19,261$36,9810.01%
OSAIC HOLDINGS, INC. 3,275,192$6,288,3450.01%
Traynor Capital Management, Inc. 34,707$66,6380.01%
Atria Wealth Solutions, Inc. 259,800$498,8160.01%
BARRETT & COMPANY, INC. 4,984$9,5690.01%
Wealthspire Advisors, LLC 183,862$353,0160.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders